Multifunctional sun-care ingredient

One ingredient.More from every formula.

PhotoSorb is a proprietary carbon-based ingredient in development for sun-care and skincare formulations. Ingredient-level studies indicate SPF-boosting performance, photostability, safety, and opportunities for formulation aesthetics and antioxidant activity — in a single platform.

For brands, formulators, manufacturers, ingredient suppliers, and commercial partners

Conceptual illustration of a carbon cage surrounding a luminous violet sphere
Conceptual visible-light interaction · not a molecular formula

SPF boosterMeasured improvement under tested formulation conditions

Photostable by designOptical function retained under controlled exposure

Formulation aesthetics + antioxidant activityAdditional design possibilities in one ingredient platform

The light problem

SPF tells only part of the light-protection story.

Sunlight reaches skin across UVB, UVA, and visible wavelengths. SPF primarily reflects protection against UVB-driven sunburn; UVA protection and visible-light performance require separate evaluation.

UVB · approximately 280–320 nm

The Foundation of SPF

UVB drives sunburn and is the primary basis of SPF. Finished-product SPF must be confirmed in the intended formulation.

UVA · approximately 320–400 nm

Essential for Broad-Spectrum Protection

UVA reaches deeper into skin and is associated with photoaging and cellular damage. Broad-spectrum or UVA protection is evaluated separately from the SPF number.

Blue light · approximately 400–450 nm

An Emerging Opportunity

Blue light is increasingly considered in formulations addressing visible-light–induced pigmentation. Protection claims require finished-product testing.

PhotoSorb is being studied as an ingredient platform that could help formulators address several optical and aesthetic objectives together. Performance depends on concentration, vehicle, companion ingredients, and finished-product testing.

The technology

Designed to do more in one ingredient.

The exact composition and manufacturing details of PhotoSorb are proprietary. Public materials use a conceptual carbon-cage illustration rather than presenting an exact molecular structure.

01

Spectral reach

Ingredient-level characterization shows absorption across UVB and UVA and into the blue-light region. Finished-product performance requires formulation-specific testing.

02

SPF booster

In formulation studies, PhotoSorb increased measured SPF performance under the tested conditions. The magnitude of any boost is formulation-specific and must be confirmed in the intended product.

03

Photostability

PhotoSorb is engineered to retain optical function under controlled UV exposure, supporting development of more durable formulation performance.

04

Tinting potential + antioxidant activity

PhotoSorb's inherent color and antioxidant activity offer formulators additional design options.

05

Surface-use design

PhotoSorb has an approximate molecular weight of 1,200 Da, well above the commonly cited 500-Da benchmark. Skin disposition still depends on formulation and requires appropriate testing.

06

Formulation flexibility

PhotoSorb can be evaluated alongside mineral and hybrid systems as formulators optimize dispersion, concentration, tint, sensory profile, and compatibility.

Evidence-led development

A broad initial in vitro safety screen.

Third-party testing evaluated PhotoSorb using internationally recognized in vitro methods. The summary below describes only the materials, concentrations, models, and conditions tested.

Genotoxicity

No genotoxic signal was observed at the tested concentration.

Not Genotoxic

Phototoxicity

No phototoxic response was observed under the tested conditions.

Not Phototoxic

Skin sensitization

No sensitization signal was observed in an in vitro gene-expression assay.

Not a Sensitizer

Skin irritation

No irritation response was observed in the tested skin-tissue model.

Not An Irritant

Eye irritation

No irritation response was observed in the tested eye-tissue model.

Not An Irritant

These results are not a complete safety determination and do not establish the safety or regulatory status of any finished product. Detailed reports are available to qualified partners during diligence.

For formulators

What PhotoSorb could mean for formulations.

PhotoSorb gives formulators a new way to explore fewer tradeoffs between optical performance, stability, safety, and cosmetic elegance.

Performance efficiency

Explore more from the same formula.

Evaluate SPF boosting while optimizing concentration, vehicle, and companion filters.

Stability design

Plan for durable performance.

Evaluate optical performance through controlled light exposure and finished-formulation stability studies.

Aesthetic integration

Develop tint with the technology.

Use inherent color while balancing tone, dispersion, compatibility, and sensory feel.

Partner-ready development

Build an evidence package together.

Co-develop prototypes, stability programs, scale-up controls, and market-specific regulatory strategies.

About Solvarna

Materials science meets modern sun care.

PhotoSorb originated in academic medical research and is being advanced by Solvarna, a materials-science company bringing together expertise in advanced materials, oncology, dermatology, and commercialization.

Our model is partner-first: co-development, ingredient supply, and licensing supported by the formulation, manufacturing, safety, and regulatory evidence each intended product requires.

“Basically, we're always working toward preventing people from becoming patients.”

Vijay Krishna, PhD · Co-founder & co-inventor
Origin
Academic medical research
Intellectual property
US, European & Australian patents
Development support
Competitive research funding
Commercial model
Co-development, ingredient supply, and licensing
01

Formulation prototypes

Optimize dispersion, concentration, tint, sensory profile, and compatibility in representative cosmetic systems.

02

Scale and validate

Advance manufacturing, quality controls, stability, and ingredient- and finished-formulation testing.

03

Commercial partnerships

Establish supply, co-development, and licensing relationships with claim- and market-specific regulatory strategies.

Featured research

Research developing new UV blockers for skin-cancer prevention

A Cleveland Clinic article highlights research on PhotoSorb.

Read the article

Founding team

Science, clinical insight, and company building.

Solvarna brings together complementary experience in materials science, oncology, dermatology, translational research, and commercialization.

Vijay Krishna, PhD

Vijay Krishna, PhD

Co-founder & co-inventor

Materials science and biomedical engineering · Cleveland Clinic

Vijay leads PhotoSorb's scientific development. He is a materials scientist and inventor on more than 25 patents and patent applications spanning advanced materials and translational medicine.

Stephen Grobmyer, MD

Stephen Grobmyer, MD

Co-founder & co-inventor

Surgical oncology and cancer-institute leadership · Cleveland Clinic Abu Dhabi

Stephen brings clinical oncology, cancer-prevention, and health-system leadership experience to PhotoSorb's development and translation.

Julie Woda, PhD

Julie Woda, PhD

Co-founder

Biotechnology translation and commercialization · Harrington Discovery Institute

Julie brings experience in venture creation, product development, financing, and commercialization, helping bridge PhotoSorb's science to partnerships and market.

Edward Maytin, MD, PhD

Edward Maytin, MD, PhD

Board member & co-inventor

Dermatology and photomedicine · Cleveland Clinic

Edward is a physician-scientist whose expertise in skin biology, photomedicine, and sun-related disease helps guide scientific and clinical strategy.

Institutional affiliations are provided for identification only and do not imply institutional endorsement.

Brands & formulators

Let's develop what comes next.

We are seeking partners for prototype formulations, manufacturing scale-up, testing, distribution, and commercial development.

Start a conversation

Partners & investors

Explore the science in depth.

Detailed spectral characterization, formulation-stage results, intellectual-property information, and third-party safety reports are available to qualified parties during diligence.

We are also advancing a seed financing round to support scale-up and commercial partnerships.

Request information package